Ciel charlotte

Design Inspiration

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+a, anti-MuSK+b adult patients with generalized myasthenia gravis (gMG) including those early in their disease, participants with lower symptom burden and those who experienced common…

Read the full release →

News provided by PR Newswire.

Olivia Bennett
Olivia Bennett writes about the people, ideas, and creative movements shaping contemporary arts and culture. Her work explores exhibitions, artists, creative communities, and the stories behind visual expression. With an accessible and observant writing style, Olivia enjoys connecting individual works of art with the larger cultural conversations surrounding creativity, identity, place, and community.